Literature DB >> 2231035

Interpretation of graphic data by patients in a general medicine clinic.

D J Mazur1, D H Hickam.   

Abstract

OBJECTIVE: To assess how patients use graphic data to decide on preferences between alternative treatments.
DESIGN: Cross-sectional survey of patients, physicians, and medical students. The physicians and medical students served as a control group with which to compare the patients' responses.
SETTING: A university-based Department of Veterans Affairs Medical Center. PARTICIPANTS: 152 patients seen in a general medicine clinic, 57 medical students, and 11 physicians. MEASUREMENTS AND
RESULTS: Subjects were given a survival graph showing the patient outcomes for two different unidentified treatments for an unidentified serious disease. They were asked to indicate which treatment they preferred and which portion(s) of the curves most influenced their preference. A large majority of both patients and health professionals preferred the treatment that had worse short-term and better long-term survival. Eleven percent of patients and 51% of health professionals identified mid-curve data (points other than the curve end-points) as most influencing their preferences.
CONCLUSIONS: A graphic survival curve appears to provide enough information to assess patient preferences between two alternative treatments. Patients appeared to differ from physicians and medical students in their interpretation of the curves.

Entities:  

Mesh:

Year:  1990        PMID: 2231035     DOI: 10.1007/bf02599425

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  11 in total

1.  The present position relating to cancer of the lung. Results with radiotherapy alone.

Authors:  G HILTON
Journal:  Thorax       Date:  1960-03       Impact factor: 9.139

2.  Eliciting preferences for alternative cancer drug treatments. The influence of framing, medium, and rater variables.

Authors:  A M O'Connor; N F Boyd; D L Tritchler; Y Kriukov; H Sutherland; J E Till
Journal:  Med Decis Making       Date:  1985       Impact factor: 2.583

3.  A system for the clinical staging of lung cancer.

Authors:  C F Mountain; D T Carr; W A Anderson
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-01

4.  On the elicitation of preferences for alternative therapies.

Authors:  B J McNeil; S G Pauker; H C Sox; A Tversky
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

5.  The framing of decisions and the psychology of choice.

Authors:  A Tversky; D Kahneman
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

6.  The measurement of patients' values in medicine.

Authors:  H Llewellyn-Thomas; H J Sutherland; R Tibshirani; A Ciampi; J E Till; N F Boyd
Journal:  Med Decis Making       Date:  1982       Impact factor: 2.583

7.  Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences.

Authors:  A M O'Connor; N F Boyd; P Warde; L Stolbach; J E Till
Journal:  J Chronic Dis       Date:  1987

8.  Assessment of patients' preferences for therapeutic outcomes.

Authors:  S A Eraker; H C Sox
Journal:  Med Decis Making       Date:  1981       Impact factor: 2.583

9.  Treatment preferences of patients and physicians: influences of summary data when framing effects are controlled.

Authors:  D J Mazur; D H Hickam
Journal:  Med Decis Making       Date:  1990 Jan-Mar       Impact factor: 2.583

10.  Fallacy of the five-year survival in lung cancer.

Authors:  B J McNeil; R Weichselbaum; S G Pauker
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245

View more
  12 in total

Review 1.  Understanding risk and lessons for clinical risk communication about treatment preferences.

Authors:  A Edwards; G Elwyn
Journal:  Qual Health Care       Date:  2001-09

2.  Communication about risk--dilemmas for general practitioners. The Department of General Practice Working Group, University of Wales College of Medicine.

Authors:  A Edwards; L Prior
Journal:  Br J Gen Pract       Date:  1997-11       Impact factor: 5.386

3.  Communicating risk. Use of standard terms is unlikely to result in standard communication.

Authors:  A Edwards; R Pill; N Stott
Journal:  BMJ       Date:  1996-12-07

4.  Distinct determinants of long-term and short-term survival in critical illness.

Authors:  Allan Garland; Kendiss Olafson; Clare D Ramsey; Marina Yogendran; Randall Fransoo
Journal:  Intensive Care Med       Date:  2014-07-11       Impact factor: 17.440

Review 5.  Design features of graphs in health risk communication: a systematic review.

Authors:  Jessica S Ancker; Yalini Senathirajah; Rita Kukafka; Justin B Starren
Journal:  J Am Med Inform Assoc       Date:  2006-08-23       Impact factor: 4.497

6.  Patient preferences for management of localized prostate cancer.

Authors:  D J Mazur; D H Hickam
Journal:  West J Med       Date:  1996 Jul-Aug

7.  Patient preferences: survival vs quality-of-life considerations.

Authors:  D J Mazur; D H Hickman
Journal:  J Gen Intern Med       Date:  1993-07       Impact factor: 5.128

8.  Cancer patients' preferences for communicating clinical trial quality of life information: a qualitative study.

Authors:  M Brundage; A Leis; A Bezjak; D Feldman-Stewart; L Degner; K Velji; L Zetes-Zanatta; D Tu; P Ritvo; J Pater
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

9.  Effect of different visual presentations on the comprehension of prognostic information: a systematic review.

Authors:  Eman Abukmail; Mina Bakhit; Chris Del Mar; Tammy Hoffmann
Journal:  BMC Med Inform Decis Mak       Date:  2021-08-25       Impact factor: 2.796

10.  The effect of alternative graphical displays used to present the benefits of antibiotics for sore throat on decisions about whether to seek treatment: a randomized trial.

Authors:  Cheryl L L Carling; Doris Tove Kristoffersen; Signe Flottorp; Atle Fretheim; Andrew D Oxman; Holger J Schünemann; Elie A Akl; Jeph Herrin; Thomas D MacKenzie; Victor M Montori
Journal:  PLoS Med       Date:  2009-08-25       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.